A non-interventional, multicenter, retrospective chart review study assessing the efficacy of tyrosine kinase inhibitors in patients with newly diagnosed chronic myeloid leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update:
08 Aug 2021
Price :
$35
*
-
Adis is an information provider.
-
Final gross price and currency may vary according to local VAT and billing address.
-
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
-
A link to download a PDF version of the trial profile will be included in your email receipt.